BIOMARIN PHARMACEUTICAL INC NOTE 1.250% 5/1 is a security (CUSIP 09061GAK7) tracked across SEC portfolio filings. 58 institutional managers reported $516.8M on Form 13F as of 2026-06-30; 4 registered fund positions totaling $20.2M via N-PORT as of 2026-05-29.
Showing 15 of 58 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | NEW YORK, NY | $108.1M | 111,500,000 |
| OAKTREE CAPITAL MANAGEMENT LP | LOS ANGELES, CA | $54.0M | 55,985,000 |
| CAPSTONE INVESTMENT ADVISORS, LLC | NEW YORK, NY | $52.3M | 54,243,000 |
| BlackRock, Inc. | New York, NY | $48.6M | 50,488,000 |
| Man Group plc | LONDON, X0 | $47.1M | 48,776,000 |
| Opti Capital Management, LP | New York, NY | $27.1M | 28,058,000 |
| MacKay Shields LLC | New York, NY | $25.7M | 26,434,000 |
| VICTORY CAPITAL MANAGEMENT INC | San Antonio, TX | $17.2M | 17,876,500 |
| JPMORGAN CHASE & CO | NEW YORK, NY | $16.9M | 17,502,000 |
| TORONTO DOMINION BANK | Toronto, Ontario, A6 | $14.3M | 14,887,000 |
| STATE STREET CORP | BOSTON, MA | $11.2M | 11,566,000 |
| DeepCurrents Investment Group LLC | NEW YORK, NY | $9.6M | 10,000,000 |
| Verition Fund Management LLC | GREENWICH, CT | $8.5M | 8,800,000 |
| BANK OF AMERICA CORP /DE/ | CHARLOTTE, NC | $8.3M | 8,606,000 |
| Daiwa Securities Group Inc. | CHIYODA-KU,TOKYO, M0 | $8.3M | 8,500,000 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| NYLI MacKay Convertible Fund | NEW YORK LIFE INVESTMENTS FUNDS | $19.0M | 105.51% |
| Miller Convertible Bond Fund | Miller Investment Trust | $969K | 25.70% |
| THRIVENT CONSERVATIVE ALLOCATION PORTFOLIO | Thrivent Series Fund, Inc. | $206K | 3.65% |
| Franklin Alternative Strategies Fund | Franklin Alternative Strategies Funds | $32K | 0.54% |